References
Siegert E, Uruha A, Goebel H-H et al (2021) Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology. Acta Neuropathol (Berl) 141:917–927. https://doi.org/10.1007/s00401-021-02305-3
Landon-Cardinal O, Leclair V, Troyanov Y, et al (2020) Scleromyositis is associated with distinct muscle vasculopathic features [abstract]. Arthritis Rheumatol 72 (suppl 10)
van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755. https://doi.org/10.1136/annrheumdis-2013-204424
Johnson SR, Fransen J, Khanna D et al (2012) Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res 64:358–367. https://doi.org/10.1002/acr.20684
Lundberg IE, Tjärnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol Hoboken NJ 69:2271–2282. https://doi.org/10.1002/art.40320
Bhansing KJ, Lammens M, Knaapen HKA, van Riel PLCM, van Engelen BGM, Vonk MC (2014) Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology. Arthritis Res Ther 16:R111. https://doi.org/10.1186/ar4562
Meyer A, Leclair V, Landon-Cardinal O, et al (2019) ACR/EULAR criteria for myositis and systemic sclerosis lack sensitivity for scleromyositis [abstract]. Arthritis Rheumatol 71 (suppl 10)
Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, Jarzabek-Chorzelska M, Targoff IN, Blaszczyk-Kostanecka M, Jablonska S (1997) Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 40:1257–1266. https://doi.org/10.1002/art.1780400710
Landon-Cardinal O, Baril-Dionne A, Hoa S et al (2020) Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. RMD Open. https://doi.org/10.1136/rmdopen-2020-001357
Allenbach Y, Benveniste O, Goebel H-H, Stenzel W (2017) Integrated classification of inflammatory myopathies. Neuropathol Appl Neurobiol 43:62–81. https://doi.org/10.1111/nan.12380
Siperstein MD, Unger RH, Madison LL (1968) Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest 47:1973–1999. https://doi.org/10.1172/JCI105886
Tilton RG, Hoffmann PL, Kilo C, Williamson JR (1981) Pericyte degeneration and basement membrane thickening in skeletal muscle capillaries of human. Diabetics 30:9
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ellezam, B., Leclair, V., Troyanov, Y. et al. Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of ‘scleromyositis’. Acta Neuropathol 142, 395–397 (2021). https://doi.org/10.1007/s00401-021-02335-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-021-02335-x